Clinical trial
Juvista (Avotermin) in the Prevention or Improvement of Scar Appearance…
NCT00432211 · Renovo, Industry · Unknown status
Key facts
| NCT number | NCT00432211 |
|---|---|
| Title | Juvista (Avotermin) in the Prevention or Improvement of Scar Appearance Following Scar Revision Surgery. |
| Official title | A Double Blind, Placebo Controlled, Randomised Trial to Investigate the Efficacy of Juvista (Avotermin) in the Prevention or Improvement of Scar Appearance Following Scar Revision Surgery. |
| Lead sponsor | Renovo, Industry |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cicatrix |
| Intervention type | Drug |
| Interventions | Avotermin |
| Enrollment | 60 |
| Start date | May 1, 2006 |
| Primary completion | Jul 1, 2008 |
| Completion | Sep 1, 2012 |
| First posted | Feb 7, 2007 |
| Last update posted | Feb 4, 2009 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: